Autopsy report · NCT03163784
SHIFT: Studying HIV Immunology After Fecal Transplant
Cause of deathFunding or business
“The study closed because of shifting research priorities and interests.”
Life of this trial
- Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.
Vital statistics
- Status
- Withdrawn
- Phase
- Phase 1, Phase 2
- Sponsor
- Massachusetts General Hospital
- Sponsor type
- University, hospital or other
- Conditions
- HIV/AIDS; Dysbiosis; Inflammation
- Interventions
- Fecal Inoculum Capsule; Placebo (for Fecal Inoculum Capsule); Antibiotic; Antibiotic Placebo
- Participants
- 0
Trials that died the same way
- Optical Frequency Domain Imaging (OFDI) in Dermatology
“The study was closed due to a shift in research priorities and a lack of resources available for the project.” - Treosulfan-Based Versus Clofarabine-Based Conditioning Before Donor Hematopoietic Stem Cell Transplant for the Treatment of Myelodysplastic Syndromes or Acute Myeloid Leukemia
“The study was closed due to the end of funding.” - Team Based Equity Conscious Telemedicine Approach to Hypertension
“closed because we were funded for another similar study” - Trastuzumab-deruxtecan in Patients With Triple-negative Metastatic HER2-Low Breast Cancer: Real-world Experience in Brazil
“The study was stopped due to a realignment of strategic priorities” - Multi-Modality Imaging for Head & Neck Cancer Free Flap Design Assessment
“We are closing this study due to the focus on other research projects and there is no time or personnel tofurther pursue the completion of this project”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.